Target-trial-emulation and cohort analyses report that diabetic patients on GLP-1R agonists develop dementia and Alzheimers disease at lower rates than those on comparator antidiabetic drugs, and pooled analyses of cardiovascular-outcome trials have pointed in the same direction [9]
Another study shows that people who worked on a mentally demanding task saw their working memory improve while taking L-tyrosine
ADHD is associated with higher rates of obesity, partly due to impulsive eating patterns and partly due to dopaminergic effects on reward processing
Some people lose a lot, some a little, and some not at all
GLP-1 medications work by mimicking the action of natural GLP-1 in the body, which increases feelings of fullness and satisfaction after eating, slows stomach emptying and reduces appetite
Ann Entomol Soc Am 55(1):124130